Literature DB >> 20392509

Increased urinary orosomucoid excretion predicts preeclampsia in pregnant women with pregestational type 1 diabetes.

M S Christiansen1, D Hesse, P Ekbom, U Hesse, P Damm, E Hommel, B Feldt-Rasmussen, E Mathiesen.   

Abstract

AIMS: We evaluated the urinary orosomucoid excretion (UOE) as a biomarker of preeclampsia and preterm delivery in pregnant women with type 1 diabetes.
METHODS: Singleton pregnant women with pregestational type 1 diabetes were included provided one urine sample had been collected before 17 gestational weeks. Serum and urinary orosomucoid were analysed by immunoturbidimetry. Primary outcome measurements were development of preeclampsia (blood pressure>140/90mmHg and proteinuria) and preterm delivery before 37 weeks.
RESULTS: In total 173 women were included. The UOE increased during pregnancy. Preeclampsia developed in 20 women and 65 women delivered preterm. Using logistic regression analysis we found that UOE>1.37mg/l (OR: 6.85 (95% CI: 1.97-23.88; p<0.003)), nulliparity (3.88 (1.10-13.72); p<0.04), systolic blood pressure>120mmHg (4.12 (1.35-12.59); p<0.02) and duration of diabetes>20 years (3.69 (1.18-11.52); p<0.03) independently predicted the development of preeclampsia. Independent predictors of preterm delivery were duration of diabetes and HbA1c>7%. The remaining covariates included in the regression models were BMI, serum creatinine, smoking and microalbuminuria.
CONCLUSIONS: Increased UOE early in pregnancy predicted preeclampsia in women with pregestational type 1 diabetes independently of albuminuria and other known risk factors. No association to preterm delivery was found.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20392509     DOI: 10.1016/j.diabres.2010.03.018

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  4 in total

1.  The increased excretion of urinary orosomucoid 1 as a useful biomarker for bladder cancer.

Authors:  Fei Li; Zhe Yu; Pengliang Chen; Guangzheng Lin; Tieqiu Li; Lina Hou; Yuejun Du; Wanlong Tan
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166

2.  Urinary orosomucoid: validation of an automated immune turbidimetric test and its possible clinical use.

Authors:  Péter Kustán; Balázs Szirmay; Zoltán Horváth-Szalai; Andrea Ludány; Ágnes Lakatos; Diána Mühl; Per Hjort Christensen; Attila Miseta; Gábor L Kovács; Tamás Kőszegi
Journal:  Biochem Med (Zagreb)       Date:  2016-10-15       Impact factor: 2.313

3.  Urinary fetuin-A is a novel marker for diabetic nephropathy in type 2 diabetes identified by lectin microarray.

Authors:  Kentaro Inoue; Jun Wada; Jun Eguchi; Atsuko Nakatsuka; Sanae Teshigawara; Kazutoshi Murakami; Daisuke Ogawa; Takahiro Terami; Akihiro Katayama; Atsuhito Tone; Izumi Iseda; Kazuyuki Hida; Masao Yamada; Tomohisa Ogawa; Hirofumi Makino
Journal:  PLoS One       Date:  2013-10-15       Impact factor: 3.240

4.  Excretion of urinary orosomucoid 1 protein is elevated in patients with chronic heart failure.

Authors:  Li-na Hou; Fei Li; Qing-chun Zeng; Liang Su; Ping-an Chen; Zhi-hao Xu; Din-ji Zhu; Chang-hua Liu; Ding-li Xu
Journal:  PLoS One       Date:  2014-09-12       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.